Skip to main content
Mural Oncology plc (MURA)
NASDAQ: MURA · Real-Time Price · USD
1.240
-0.020 (-1.59%)
At close: Apr 1, 2025, 4:00 PM
1.290
+0.050 (4.03%)
After-hours: Apr 1, 2025, 4:22 PM EDT

Mural Oncology Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21
Selling, General & Admin
37.940.8127.6325.25
Research & Development
100.37155.43157.29150.12
Operating Expenses
138.26196.24184.92175.37
Operating Income
-138.26-196.24-184.92-175.37
Other Non Operating Income (Expenses)
9.750.95--
Pretax Income
-128.51-195.29-184.92-175.37
Income Tax Expense
-12.164.880.07
Net Income
-128.51-207.45-189.81-175.43
Net Income to Common
-128.51-207.45-189.81-175.43
Shares Outstanding (Basic)
171717-
Shares Outstanding (Diluted)
171717-
Shares Change (YoY)
1.59%---
EPS (Basic)
-7.58-12.43-11.37-
EPS (Diluted)
-7.58-12.43-11.37-
Free Cash Flow
-128.64-197.7-174.1-161.05
Free Cash Flow Per Share
-7.59-11.85-10.43-
EBITDA
-134.75-193.67-183.38-173.89
D&A For EBITDA
3.512.571.541.47
EBIT
-138.26-196.24-184.92-175.37
Updated Mar 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q